BridgeBio

3 weeks ago

Senior Director, Market Access Strategy, International

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI

Last checked: 4 hours agoStatus: Live

Job Summary

Lead international market access strategy to secure timely, sustainable patient access by shaping value narratives and driving pricing and reimbursement execution across multiple markets. Oversee related dossiers, negotiations, and cost-coverage approaches while aligning Market Access ambitions with clinical value and global pricing interdependencies. Serve as a core member of the International Market Access team, partner with HEOR, commercialization, and clinical development leaders, and lead early engagement with HTA/payer bodies worldwide.

Location: Switzerland

Workplace: Hybrid

Employment Type: Full time

Job Function: Strategy & Corporate Development

Seniority: Sr. Director level

Key Responsibilities

•Represent the payer perspective within cross-functional, cross-regional commercialization teams to optimize pricing and market access.
•Collaborate with HEOR and clusters leadership, Marketing, and Clinical Development to optimize value and access for the asset.
•Lead early payer engagement with key HTA/payer bodies to inform evidence generation strategy, value proposition, and reimbursement dossier development.
•Interact with internal and external experts (pricing, health economics, patient advocacy, HTA authorities, government policy makers, and payers) to execute pricing and reimbursement objectives.
•Train and support local access teams on negotiation strategy and ensure HTA and reimbursement submissions align with Global and International strategy.

Pay and Benefits

Perks:401kHealth InsuranceDentalVisionHsaFsaEquityPaid LeaveParental LeaveAnnual BonusCommuter Benefits

Key Requirements

•Extensive experience leading HTA submissions and pricing negotiations across multiple international markets, ideally including Europe and rare diseases/orphan conditions.
•Strong knowledge of international healthcare systems, pricing and reimbursement frameworks, and regulatory environments.
•Experience generating and leveraging data for HTA submissions and pricing negotiations, with an external network of agencies and stakeholders.
•Ability to present at senior levels and engage with external thought leaders globally.
•Proven experience managing complex, cross-functional and multicultural teams (including external partners).

Experience:BiopharmaBiotechnologyRare diseasesOrphan conditions

Skills:CollaborationCommunicationAdaptabilityStakeholder managementLeadership

Languages:English

Company Brief

BridgeBio

Develops medicines for patients with genetic diseases by advancing targeted therapeutics from discovery through clinical development and commercialization, focusing on genetically defined diseases with high unmet medical need.

Industry: Biotech

Company Size: Large (251 to 1,000 employees)

Growth: Public Company

Valuation: Public Company (Market Cap in USD)

Funding: IPO / Publicly Listed

Headquarters: Palo Alto, United States

Founded: 2015

Website LinkedIn

Loading job details...

Preparing the role view and application actions.

BridgeBio

3 weeks ago

Senior Director, Market Access Strategy, International

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI

Last checked: 4 hours agoStatus: Live

Job Summary

Location: Switzerland

Workplace: Hybrid

Employment Type: Full time

Job Function: Strategy & Corporate Development

Seniority: Sr. Director level

Key Responsibilities

•Represent the payer perspective within cross-functional, cross-regional commercialization teams to optimize pricing and market access.
•Collaborate with HEOR and clusters leadership, Marketing, and Clinical Development to optimize value and access for the asset.
•Lead early payer engagement with key HTA/payer bodies to inform evidence generation strategy, value proposition, and reimbursement dossier development.
•Interact with internal and external experts (pricing, health economics, patient advocacy, HTA authorities, government policy makers, and payers) to execute pricing and reimbursement objectives.
•Train and support local access teams on negotiation strategy and ensure HTA and reimbursement submissions align with Global and International strategy.

Pay and Benefits

Perks:401kHealth InsuranceDentalVisionHsaFsaEquityPaid LeaveParental LeaveAnnual BonusCommuter Benefits

Key Requirements

•Extensive experience leading HTA submissions and pricing negotiations across multiple international markets, ideally including Europe and rare diseases/orphan conditions.
•Strong knowledge of international healthcare systems, pricing and reimbursement frameworks, and regulatory environments.
•Experience generating and leveraging data for HTA submissions and pricing negotiations, with an external network of agencies and stakeholders.
•Ability to present at senior levels and engage with external thought leaders globally.
•Proven experience managing complex, cross-functional and multicultural teams (including external partners).

Experience:BiopharmaBiotechnologyRare diseasesOrphan conditions

Skills:CollaborationCommunicationAdaptabilityStakeholder managementLeadership

Languages:English

Company Brief

BridgeBio

Industry: Biotech

Company Size: Large (251 to 1,000 employees)

Growth: Public Company

Valuation: Public Company (Market Cap in USD)

Funding: IPO / Publicly Listed

Headquarters: Palo Alto, United States

Founded: 2015

Website LinkedIn